- Q3 revenue $1.34B, +11% YoY
- Adj. EPS $0.73, +20% YoY
Dexcom reported Q3 revenue of $1.34B (est. $1.33B) and adj. EPS of $0.73 (est. $0.67). The company raised its FY26 revenue guidance to $5.20B-$5.25B. US revenue grew 14% YoY; international grew 5%. Gross margin improved 380 bps to 65.1%. Also announced $1B share repurchase authorization.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.